Perrigo Reports Q2 2026 Financial Results, Reaffirms Full-Year Guidance, and Advances Portfolio Simplification

Perrigo Company plc announced its second-quarter 2026 financial results from continuing operations, reaffirming its full-year 2026 outlook. The company also completed the sale of its Dermacosmetics business and is continuing strategic reviews of its Infant Formula and Oral Care businesses, aiming to become a more focused consumer self-care company.